Tobias Tenenbaum Selected Research

Therapeutics

1/2024	Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.
5/2023	Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021: a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process.
3/2021	Emergence of Macrolide-Resistant Mycoplasma pneumoniae during an Outbreak in a Primary School: Clinical Characterization of Hospitalized Children.
8/2020	Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection - a comparative, retrospective analysis.
11/2015	Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
2/2014	Multiple aseptic splenic abscesses in a 15 year old patient.
9/2008	Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Tenenbaum Research Topics

Disease

18	Infections 01/2024 - 07/2006
3	Fever (Fevers) 01/2023 - 08/2010
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 03/2021
3	Pneumonia (Pneumonitis) 03/2021 - 08/2002
3	Choroid Plexus Papilloma 01/2020 - 01/2012
3	Meningitis 01/2017 - 09/2014
3	Coinfection 08/2010 - 07/2008
2	Respiratory Syncytial Virus Infections 01/2024 - 08/2020
2	Virus Diseases (Viral Diseases) 05/2022 - 12/2008
2	COVID-19 01/2022 - 01/2022
2	Human Influenza (Influenza) 08/2020 - 01/2011
2	Multiple Sclerosis 01/2020 - 07/2014
2	Bacterial Infections (Bacterial Infection) 05/2013 - 02/2013
2	Bacterial Meningitis 02/2013 - 09/2008
1	Lung Diseases (Lung Disease) 01/2024
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2023
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Febrile Neutropenia 05/2023
1	Viral Encephalitis 01/2022
1	Otitis Media 08/2020
1	Aseptic Meningitis 06/2020
1	Headache (Headaches) 11/2019
1	Muscle Rigidity 11/2019
1	Central Nervous System Infections (Central Nervous System Infection) 11/2019
1	Measles 05/2016
1	Rubella (German Measles) 05/2016
1	Anaphylaxis (Anaphylactic Shock) 05/2016
1	Central Nervous System Viral Diseases 01/2016
1	Meningococcal Infections 11/2015
1	Papilloma (Papillomatosis) 09/2014
1	Anemia 07/2014
1	Thrombocytopenia (Thrombopenia) 07/2014
1	Abscess 02/2014
1	Exanthema (Rash) 05/2013
1	Acute Kidney Injury (Acute Renal Failure) 02/2012
1	Asymptomatic Infections 01/2011
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2008
1	Tonsillitis 12/2008
1	Hypertrophy 12/2008
1	Hemorrhage 12/2008
1	Airway Obstruction (Choking) 12/2008
1	Bronchitis 07/2008
1	Bronchiolitis 07/2008
1	Necrosis 07/2006

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 09/2008
7	CytokinesIBA 01/2020 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2008
5	ChemokinesIBA 01/2020 - 12/2012
3	VaccinesIBA 05/2016 - 11/2015
2	Monoclonal AntibodiesIBA 01/2024 - 12/2023
2	C-Reactive ProteinIBA 05/2022 - 08/2020
2	Oxygen (Dioxygen)IBA 03/2021 - 08/2020
2	Dextrans (Dextran)FDA Link 11/2019 - 02/2018
1	beta-Lactamase InhibitorsIBA 01/2024
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	LigandsIBA 05/2022
1	InterferonsIBA 05/2022
1	MacrolidesIBA 03/2021
1	LipidsIBA 12/2020
1	Complementary DNA (cDNA)IBA 08/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2020
1	AntigensIBA 01/2020
1	Chemokine CXCL12IBA 11/2019
1	RNA (Ribonucleic Acid)IBA 01/2017
1	PR 39IBA 01/2017
1	Interleukin-7 (Interleukin 7)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Dynamins (Dynamin)IBA 01/2017
1	CathelicidinsIBA 01/2017
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2016
1	eculizumab FDA Link 11/2015
1	Complement System Proteins (Complement)IBA 11/2015
1	ProperdinIBA 11/2015
1	EnzymesIBA 09/2014
1	Capsules (Microcapsules)IBA 09/2014
1	ImmunosorbentsIBA 09/2014
1	Pattern Recognition ReceptorsIBA 09/2014
1	Natalizumab (Tysabri)FDA Link 07/2014
1	Meropenem (Merrem)FDA LinkGeneric 02/2014
1	Metronidazole (Metric)FDA LinkGeneric 02/2014
1	Glycoproteins (Glycoprotein)IBA 02/2013
1	Interleukin-8 (Interleukin 8)IBA 12/2012
1	Chemotactic FactorsIBA 12/2012
1	ExotoxinsIBA 06/2012
1	AntibodiesIBA 01/2011
1	SteroidsIBA 08/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2008
1	N 30IBA 07/2008
1	CaspasesIBA 07/2006
1	HMGB1 Protein (HMG1)IBA 07/2006
1	Caspase 3 (Caspase-3)IBA 07/2006
1	EndotoxinsIBA 08/2002

Therapy/Procedure

7	Therapeutics 01/2024 - 09/2008
2	Stem Cell Transplantation 01/2022 - 04/2002
1	Tracheostomy 01/2024
1	Critical Care (Surgical Intensive Care) 01/2022
1	Length of Stay 11/2019
1	Tonsillectomy 12/2008